Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 19, 2015 16:00 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics Data Demonstrates Novel Antimicrobial Activity of AR-12, Identified it as Lead Compound of New Class of Drugs

FLEMINGTON, N.J., Sept. 19, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for cancer...
September 19, 2015 08:00 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics to Present Data on Trans-Fungal Delivery of AR-12 at 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Exposition

FLEMINGTON, N.J., Sept. 19, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for cancer...
September 14, 2015 08:00 ET | Source: Arno Therapeutics Inc.

AR-12 Abstracts Accepted for Podium Presentation and Three Posters at ICAAC/ICC Annual Meeting 2015

FLEMINGTON, N.J., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for cancer...
September 01, 2015 08:30 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics to Present at 17th Annual Rodman & Renshaw Conference

FLEMINGTON, N.J., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics,...
August 18, 2015 08:30 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics Receives Authorization to Proceed With Modified Phase I/II Trial Evaluating Onapristone in Prostate Cancer

FLEMINGTON, N.J., Aug. 18, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of therapeutics for cancer and other...
August 14, 2015 17:03 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics Reports Second Quarter 2015 Financial Results and Business Update

FLEMINGTON, N.J., Aug. 14, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of therapeutics for cancer and other...
June 04, 2015 08:30 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics Announces Issuance of First Onapristone Patent

FLEMINGTON, N.J., June 4, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for cancer and...
June 03, 2015 08:30 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics Announces Cooperative Research and Development Agreement With US Army Medical Research Institute of Infectious Diseases to Test Antiviral Activity of AR-12

FLEMINGTON, N.J., June 3, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for the...
May 28, 2015 11:15 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics Announces AR-12 Antiviral Data Against Multiple Hemorrhagic Fevers Published Online in Antiviral Research

FLEMINGTON, N.J., May 28, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on developing therapeutics in cancer and other life...
May 15, 2015 16:35 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics Reports First Quarter 2015 Financial and Business Update

FLEMINGTON, N.J., May 15, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of therapeutics for cancer and other life...